Skip to main content
Download PDF
- Main
Can PRAME immunohistochemistry be used to differentiate sebaceous carcinoma from basal cell carcinoma?
- Doost, Mohammad S;
- Ortega-Springall, Maria Fernanda;
- Meyer, Summer N;
- Love, Nick R;
- Konia, Thomas;
- Fung, Maxwell A;
- Kiuru, Maija
The data associated with this publication are not available for this reason: N/A
Abstract
The histopathology of sebaceous carcinoma (SBC) can mimic other skin neoplasms, including basal cell carcinoma (BCC).Therefore, diagnostic biomarkers are needed for a subset of cases. Normal sebaceous glands express PRAME (PRAME nuclearreceptor transcriptional regulator), a melanoma-associated biomarker.Donell et al. showed that PRAME has strong immunoreactivity with basaloid sebocytes in SBC. Ng et al. reported patchy cytoplasmic staining in the germinative sebocytes only.Sebaceous glands (H&E stain and PRAME stain)
Objective: to evaluate the utility of PRAME immunohistochemistry as a diagnostic biomarker for SBC and its usefulness in the distinction of SBC from BCC.